Fiche de BRUNOTTE François

Depuis 2017 : Pr Emérite, Université de Bourgogne

1991-2017 : PU-PH en Biophysique et Médecine nucléaire, Université de Bourgogne

1989-1990 : Année de recherche Department of Biochemistry University of Oxford

1990 : Doctorat d’Université,  Université de Nancy

1986 : Docteur en Médecine, Université de Nancy

PET/MRI in preclinical Imaging

Selected publications
Respective contribution of baseline clinical data, tumour metabolism and tumour blood-flow in predicting pCR after neoadjuvant chemotherapy in HER2 and Triple Negative breast cancer. Payan N, Presles B, Coutant C, Desmoulins I, Ladoire S, Beltjens F, Brunotte F, Vrigneaud JM, Cochet A. EJNMMI Res. 2024 Jul 4;14(1):60

A practical quality assurance procedure for data acquisitions in preclinical simultaneous PET/MR Systems. Courteau A, McGrath J, Walker PM, Presles B, Garipov R, Cochet A, Brunotte F, Vrigneaud JM. Mol Imaging Biol. 2023 Jun;25(3):450-463.

Critical analysis of the effect of various methodologies to compute breast cancer tumour blood flow-based texture features using first-pass 18F-FDG PET.

Payan N, Presles B, Truntzer C, Courcet E, Coutant C, Desmoulins I, Brunotte F, Vrigneaud JM, Cochet A.Phys Med. 2022 Nov;103:98-107.

[123I]MIBG is a better early marker of anthracycline cardiotoxicity than [18F]FDG: a preclinical SPECT/CT and simultaneous PET/MR study. Oudot A, Courteau A, Guillemin M, Vrigneaud JM, Walker PM, Brunotte F, Cochet A, Collin B. EJNMMI Res. 2021 Sep 20;11(1):92.

Performance evaluation and compatibility studies of a compact preclinical scanner for simultaneous PET/MR imaging at 7 tesla. Courteau A, McGrath J, Walker PM, Pegg R, Martin G, Garipov R, Doughty P, Cochet A, Brunotte F, Vrigneaud JM. IEEE Trans Med Imaging. 2021 Jan;40(1):205-217.

Participations aux masters internationaux :

-Innovative drugs

-Health-AI

-Medical Imaging and applications